KF 17837

Drug Profile

KF 17837

Alternative Names: KF 17837S

Latest Information Update: 12 Jan 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kyowa Hakko
  • Class Antidepressants; Antiepileptic drugs; Antiparkinsonians; Neuroprotectants; Small molecules; Xanthines
  • Mechanism of Action Adenosine A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Parkinson's disease

Most Recent Events

  • 12 Jan 2001 No-Development-Reported for Parkinson's disease in Japan (Unknown route)
  • 01 Dec 1997 Phase-I clinical trials for Parkinson's disease in Japan (Unknown route)
  • 30 Dec 1996 A study has been added to the Parkinson's Disease and Movement Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top